57 A PHASE 2 MULTICENTER STUDY OF CC-486 (ORAL AZACITIDINE) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS) WHO FAIL TO ACHIEVE RESPONSE WITH INJECTABLE AZACITIDINE OR DECITABINE
Garcia-Manero, G., Silverman, L.R., Komrokji, R.S., Mufti, G.J., Seymour, J.F., Tsai, K., Reiser, D., Skikne, B.S., Beach, C.L., Fenaux, P.Volume:
39
Language:
english
Journal:
Leukemia Research
DOI:
10.1016/S0145-2126(15)30058-8
Date:
April, 2015
File:
PDF, 152 KB
english, 2015